winningstreak
18 Oct 2016
Re: New earnings-enhancing acquisition Trusset - Paul Parmar is Paul Parmar the CEO. He has done some 'interesting' property transactions, his life-style can be described as high and colourful, IMHO.WS
gretel
17 Oct 2016
Re: Surging - tipped by Simon Thompson A poster elsewhere has noted re ST's article as follows:" I see in Friday's actual Investors Chronicle, he strongly recommends CHT for the reasons you show. He highlights the recurring nature of the business with two thirds of last years revenue on two to five year contracts "I suspect that once the City latches on to this CHT should achieve a premium rating in due course - up to double the present P/E of only 10 or so.
frusset
15 Oct 2016
Re: New earnings-enhancing acquisition I can't find a "colourful" past for Paul Parmjit Parmar. "Paul Parmjit Parmar" is the name on the Board of Directors page [link] where the bio is sketchy. I found stuff about "Paul Parmar, a private-equity investor" who is "Parmjit Singh Parmer" on property deeds, but found no proof they are the same person.I found a positive outlook for the Global Medical Billing Outsourcing Market [link] from a market research firm who'll let you see you their full report for $5K. I'm not convinced that selling reports for $5K means they're right. It mentions four key vendors vying for market share. None of them look pure play e.g. Accenture.
gretel
10 Oct 2016
Surging - tipped by Simon Thompson Here's the conclusion - 250p would be a reasonable first stop, but if CHT continue to deliver on their strategy, along with further acquisitions, it should garner a much higher rating than a P/E of 11.5 at that 250p:[link] having weighed up the risks, and the current valuation, I feel Constellation's shares are being too lowly rated at the current level. In fact, I believe that a target price of 250p is not unreasonable, implying a forward PE ratio of 11.5 for 2017, and an enterprise value to cash profit multiple of 5.3 times.Interestingly, a share price move above the all-time high of 190p dating back to May 2015 would be a very bullish sign, and one that is likely once investors cotton onto the value on offer. Offering 40 per cent upside to my target price, I rate Constellation's shares a strong buy on a bid-offer spread of 173p to 178p."
gretel
10 Oct 2016
Current year P/E of only 9.5 at 173p Share.com has rather higher forecasts for this year than Hemscott, which I suspect are the analyst forecasts in dollars translated at more recent rates. These are: this year : 18.13p EPS next year : 20.54p EPS[link]
gretel
07 Oct 2016
Finncap increase forecasts again Finncap have increased their forecasts AGAIN. They now go for:this year : 16.97p EPSnext year : 20.75p EPSPretty cheap against a 173p share price.
gretel
05 Oct 2016
Big buy trade today 250,000 just bought at 174p. Good to see decent size trades - maybe more still to be reported.
gretel
30 Sep 2016
Nice surge yesterday in the afternoon. CHT is perhaps attracting some American buying interest.Either that or the merits of the acquisition are sinking in. Finncap will presumably be increasing next year's forecast from the current 18.84p EPS.
winningstreak
23 Sep 2016
Re: New earnings-enhancing acquisition Gretel - Take care not to get starry-eyed about Parmar. To me, his actions remind me of Mr Terry at Quindell, indeed his acquisitionsalso remind me of Mr Terry. $24m for $8m annual profit....what foolthe seller....? Don't tell me the yanks have gone soft in the head.Sorry to be so negative here.ws
gretel
23 Sep 2016
New earnings-enhancing acquisition As if CHT wasn't cheap enough on a single-figure forward P/E, today we have a big $24m earnings-enhancing acquisition of VEGA Medical:[link] the proposed synergies come about, CHT will have paid just $24m for a business making almost $8m EBITDA.....Apparently according to Finn Cap, VEGA is a holding company. The underlying company CHT have bought is Allegiance Billing & Consulting, LLC:[link] to borrow the money instead of diluting further with a large share issue. Presumably the CEO's loan facility was speediest to facilitate this acquisition quickly and efficiently. The terms aren't ideal, but I do see this as another indication of his commitment to CHT being a success over time as his eventual equity holding is going to be even larger, and in the meantime it's worth noting that he's put an awful lot of his own money on the line without any security at all.
winningstreak
23 Sep 2016
Paul Parmer CEO Paul Parmar lends CHT $12m at 7.5%. See acquisition statement (RNS).Make of it what you will, Parmar is getting a fat rate of interest. Where are thebanks gone?ws
gretel
21 Sep 2016
New highs, but still cheap imho Rising again - at 175p CHT must almost be on a double-figure ex-cash P/E now. Though not for next year yet, with 18.84p EPS forecast and $10m in the bank.
gretel
14 Sep 2016
Moving up again Very interesting trade just reported - a £28,000 buy at 175p. That's a full 5p above the published offer price at the time. Certainly keen.I really recommend reading CHT's full Annual Report - the Chairman's Review, Strategic Review and Key Strengths sections aren't shown in the RNS version and are most informative:[link] I particularly like this from the Key Strengths:"Recurring revenue base – the Group’s RCM division typically enters into customer contracts which have two to five year terms that auto-renew for additional one year periods thus providing some visibility of future revenues. The Group’s RCM division generated revenues for the year ended 31 December 2015 of approximately $50.1m (representing approximately 65.4% of Group revenue). In addition, the Group’s PM division provides business, administrative and practice management services to physicians under a 40-year management agreement. The PM division has provided a base of stable and growing revenues historically."
gretel
13 Sep 2016
New recent highs Breaking upwards now.This morning's buyer at 165p has already been warded with a rise. Given the lack of free float, and the apparent clearance of the seller, things could get extremely interesting here with any further demand.We could see 200p within a few days for starters imo with a bit of buying and a little press interest.Before next aiming for Finncap's 310p target - almost double the current share price.
winningstreak
13 Sep 2016
Re: Moving up, new recent highs Gretel - Time will tell whether my concerns about Mr Parmar are justified.SOM is a different kettle of fish, operating soundly with no overspendinghigh living Mr Parmar at the helm.ws
